Protean agonism at histamine H3 receptors in vitro and in vivo

作者: F. Gbahou , A. Rouleau , S. Morisset , R. Parmentier , S. Crochet

DOI: 10.1073/PNAS.1932276100

关键词:

摘要: G protein-coupled receptors (GPCRs) are allosteric proteins that adopt inactive (R) and active (R*) conformations in equilibrium. R* is promoted by agonists or occurs spontaneously, leading to constitutive activity of the receptor. Conversely, inverse promote R decrease activity. The existence another pharmacological entity, referred as “protean” (after Proteus, Greek god who could change shape), was assumed on theoretical grounds. It predicted from a same ligand this class act either an agonist at GPCR. Here, we show proxyfan, high-affinity histamine H3-receptor ligand, acts protean recombinant H3 expressed Chinese hamster ovary cells. In support physiological relevance process, proxyfan also behaves native known display On neurochemical behavioral responses rodents cats, displays spectrum ranging full agonism agonism. Thus, demonstrates ligand-directed states LR* different from, competing with, constitutively GPCRs, defines entity with important therapeutic implications.

参考文章(34)
Helmut L. Haas, Jean-Charles Schwartz, The Histamine receptor Wiley-Liss. ,(1991)
P. Samama, S. Cotecchia, T. Costa, R.J. Lefkowitz, A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. Journal of Biological Chemistry. ,vol. 268, pp. 4625- 4636 ,(1993) , 10.1016/S0021-9258(18)53442-6
Régis Parmentier, Hiroshi Ohtsu, Zahia Djebbara-Hannas, Jean-Louis Valatx, Takehiko Watanabe, Jian-Sheng Lin, Anatomical, Physiological, and Pharmacological Characteristics of Histidine Decarboxylase Knock-Out Mice: Evidence for the Role of Brain Histamine in Behavioral and Sleep–Wake Control The Journal of Neuroscience. ,vol. 22, pp. 7695- 7711 ,(2002) , 10.1523/JNEUROSCI.22-17-07695.2002
Séverine Morisset, Agnès Rouleau, Xavier Ligneau, Florence Gbahou, Joël Tardivel-Lacombe, Holger Stark, Walter Schunack, C. Robin Ganellin, Jean-Michel Arrang, High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature. ,vol. 408, pp. 860- 864 ,(2000) , 10.1038/35048583
Karl E. O. Akerman, Ge Huifang, Jyrki P. Kukkonen, Vic Cockcroft, Christian C. Jansson, Johnny Nasman, Raimo Virtanen, Juha-Matti Savola, Siegfried Wurster, Protean agonism at alpha2A-adrenoceptors. Molecular Pharmacology. ,vol. 53, pp. 963- 968 ,(1998)
M Garbarg, X Ligneau, W Schunack, H Stark, J C Schwartz, M L Vizuete, J Diaz, K Purand, [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors. Journal of Pharmacology and Experimental Therapeutics. ,vol. 271, pp. 452- 459 ,(1994)
P Chidiac, M Bouvier, S Nouet, Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor. Molecular Pharmacology. ,vol. 50, pp. 662- 669 ,(1996)
N Akaike, Y Takeshita, T Watanabe, T Sakata, M Munakata, H Ishibashi, Histamine modulates high-voltage-activated calcium channels in neurons dissociated from the rat tuberomammillary nucleus Neuroscience. ,vol. 87, pp. 797- 805 ,(1998) , 10.1016/S0306-4522(98)00152-3
T. Costa, A. Herz, Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins Proceedings of the National Academy of Sciences of the United States of America. ,vol. 86, pp. 7321- 7325 ,(1989) , 10.1073/PNAS.86.19.7321
Paul Leff, THE TWO-STATE MODEL OF RECEPTOR ACTIVATION Trends in Pharmacological Sciences. ,vol. 16, pp. 89- 97 ,(1995) , 10.1016/S0165-6147(00)88989-0